Long Term Care Market Projected To Expand At A CAGR Of 7.5% % For The Forecast Period 2019 To 2026: Grand View Research Inc.

San Francisco, 30 August 2019: The Report Long Term Care Market Size, Share & Trends Analysis Report By Service (Home Healthcare, Hospice, Nursing Care, Assisted Living Facilities), By Region, Competitive Landscape, And Segment Forecasts, 2019 – 2026

The global long term care market size is expected to reach USD 1.7 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.5% CAGR during the forecast period. The market is expected to grow primarily owing to rising prevalence of target diseases, especially Alzheimer’s and other dementias, among the aging population. In addition to this, increasing awareness about different long term care (LTC) facilities and the increasing medical coverage for home healthcare are likely to benefit market growth.

According to data published by the United Nations in 2017, it has been estimated that the number of people above 60 of years of age is expected to double between 2017 and 2050. In 2017, the geriatric population was estimated to be 962 million globally. In August 2018, it was estimated that around 52.0% of the people turning 65 years are more likely to take rely on some type of LTC services in the years to come. There has also been a shift toward in-home care from LTC. The number of nursing facilities has reduced over the past several years, while the prevalence of in-home nursing programs have doubled.

Developing economies make for lucrative markers as far as home healthcare is concerned. India, for instance, has many home healthcare startups such as Health Care at Home, Zoctr, Vatsalya, Zozz, Life Circle Health Services, Healers at Home, and the Nightingales, a factor that has worked in its favor. In India, Portea is one of the market leaders in home healthcare. In November 2017, Portea raised USD 26.0 million in the Series C funding for better home healthcare facilities.

Growing medical coverage by government and private insurers has had a positive impact on market growth. According to the Hospice Association of America, Medicare pays USD 173 per day for inpatient respite care, USD 744 per day for general inpatient care, USD 193 per day for routine homecare, and USD 41 per hour for continuous homecare. Moreover, in 2016, Medicare paid a total of USD 16.9 billion to hospice providers, and the average spending per Medicare hospice patient was USD 11,820.0.

Access Research Report of Long Term Care Market www.grandviewresearch.com/industry-analysis/long-term-care-services-market

Further key findings from the study suggest:

  • In 2018, the home healthcare segment held the largest market share owing to increasing awareness regarding such facilities, cost savings offered by them as compared to hospital stays or nursing homes, and proactive health monitoring
  • The home healthcare segment is expected to witness rapid growth in developing nations owing to increasing need for geriatric care, presence of double-income households, and ongoing social changes
  • Hospice is the fastest growing segment owing to increasing incidence rate of Alzheimer’s and dementia and an increase in post-hospital care. Moreover, the coverage offered by both Medicaid and private insurers has relieved residents from out-of-pocket payments that have to be borne by them
  • North America dominated the long term care market in 2018, majorly driven by advanced medical infrastructure, awareness about the advantages of home health services, rising geriatric population, and government support. Around 13% of the people in U.S. are 65 years or above and it is expected that by 2050, one in five Americans would be at least 65 years of age
  • Asia Pacific is the fastest growing market owing to increasing rate of chronic diseases, the increasing disposable incomes, and decreasing working population. For instance, in China, the one-child policy has eventually decreased the working population as compared to the older population
  • Industry players are continuously investing in expanding and revamping existing facilities. For instance, in February 2019, Genesis HealthCare underwent a real estate partnership with Next Healthcare Capital. The deal involved 15 skilled nursing facilities previously leased from Welltower Inc.
  • Key players operating in the global market include Brookdale Senior Living, Inc.; Sunrise Carlisle, LP; Atria Senior Living Group; Extendicare, Inc.; Senior Care Centers of America; Kindred Healthcare, Inc.; Genesis Healthcare Corp.; Home Instead Senior Care, Inc.; Capital Senior Living Corporation; and Diversicare Healthcare Services, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global long term care market based on service and region:

LTC Service Outlook (Revenue, USD Billion, 2015 – 2026)

  • Home healthcare
  • Hospices
  • Nursing care
  • Assisted living facilities

LTC Regional Outlook (Revenue, USD Billion, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Long Term Care Market www.grandviewresearch.com/press-release/global-long-term-care-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cord Blood Banking Services Market Poised To Augment The Industry At $82.3 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 August 2019: The Report Cord Blood Banking Services Market Size & Growth Analysis Report, By Bank Types (Public, Private, Hybrid) By Region (North America, Europe, Asia Pacific, LATAM, MEA), And Segment Forecasts, 2018 – 2025

The global cord blood banking services market is expected to reach over USD 82.3 billion by 2025, growing at an estimated CAGR of around 11.9% from 2017 to 2025, according to a new study by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapies in disease treatment, and rising prevalence of life threatening genetic disorders.

Moreover, increasing spending capacity is fueling the demand for advanced healthcare facilities including disease prevention and treatment. As a result, parents are increasingly demanding CBB services to ensure safety of their child’s future. Furthermore, private players are practicing marketing activities which are creating awareness about the availability of the CBB services and their benefits.

In addition, governments worldwide are promoting public CBB to develop ethnically diverse cord blood repository which would increase the chances of finding suitable human leukocyte antigen (HLA) match for the patients. As a result, availability of the ethnically rich CB repository coupled with anticipated rise in the stem cell therapies and bone marrow transplants, is expected to spur the CBB services during the forecast period.

Access Research Report of Cord Blood Banking Services Market www.grandviewresearch.com/industry-analysis/cord-blood-banking-services-market

Further Key Findings From the Report Suggest:

  • Private bank segment accounted for the largest revenue share in 2016. High cost of collection, processing, and storage along with the maximum awareness created by marketing activities practiced by the players resulted in large revenue share of private banks across the globe.
  • Rising government support and no storage and collection costs are the major factors anticipated to drive the public banking sector during the forecast period from 2017 to 2025 with highest CAGR.
  • North America dominated the global market and was followed by Europe in 2016. Dominance of North America is owing to government support and high rate of stem cell therapy in the U.S. and Canada.
  • Moreover, high awareness and insurance coverage of cord blood banking and stem cell therapies is further boosting the growth of the market in North America
  • Densely populated emerging countries of Asia Pacific are anticipated to show significant growth during the forecast period from 2017 to 2025.
  • Factors such as increasing investment by global players, government support and rising healthcare expenditure are anticipated to boost the cord blood banking services market in Asia Pacific
  • Global CBB services sector is highly fragmented with presence of many private and public players. Few global players operate in various geographies through subsidiaries. While local players are operating independently in respective geographies.
  • Key players of this market include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc. and Virgin Health Bank

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global cord blood banking services market on the basis of bank type, and region:

Cord Blood Banking Services Bank Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Private
  • Public
  • Hybrid

Cord Blood Banking Services Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Cord Blood Banking Services Market www.grandviewresearch.com/press-release/global-cord-blood-banking-service-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Patient Portal Market Estimated To Witness A Noteworthy CAGR Of 17.6% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.

San Francisco, 30 August 2019: The Report Patient Portal Market Size, Share & Trend Analysis By Type (Standalone, Integrated), By Delivery Mode (Web-based, Cloud-based), By End Use (Providers, Payers, Others), By Region, And Segment Forecasts, 2019 – 2026

The global patient portal market size is expected to reach USD 7.0 billion by 2026, according to a new report by Grand View Research, Inc. expanding at a CAGR of 17.6% over the forecast period. The demand for Electronic Health Record (EHR) with a patient portal is expected to exhibit an upsurge over the forecast period, owing to the increasing demand, favorable government funding policies, and the continual technological advancements offered by the key industrial players.

Patient portal technology has emerged due to introduction of the HITECH 2009 Act. It has become crucial for healthcare providers to understand patient perspectives in terms of health data. Patient portal solutions offer convenient usage and better care management. In May 2016, CureMD signed a pledge of Voluntary National Interoperability. This pledge stated that action plans to develop and implement rapid flow in healthcare information between providers, patients, and other concerned authorities are to be implemented.

ICON, a global drug development and service provider, launched its online “Firecrest Patient Portal” in 2015. This patient portal is specifically designed for individual patients to understand their entire treatment process before consulting the provider and view information regarding clinical trials. The portal offers services such as online appointment registration, laboratory tests and reports, and other necessary facilities.

Access Research Report of Patient Portal Market www.grandviewresearch.com/industry-analysis/patient-portal-market

Further Key Findings From the Study Suggest:

  • Integrated patient portal segment was identified as the most lucrative segment in 2018 owing to the rapid shift of providers from their previous methods to the EHRs
  • Web-based patient portals dominated the market in 2018 in terms of market share due to improved efficiency, affordability, and convenient user interface
  • Cloud-based portals, on the other hand, are anticipated to witness the fastest growth rate in the coming years
  • Healthcare providers held a majority of the end use segment in the patient portal market in 2018. In addition, providers are expected to be the fastest growing segment over the forecast period from 2019 to 2026.
  • North America dominated the overall market in 2018 due to the technological advancements and implementation of healthcare IT in the region. Asia Pacific is expected to be the fastest growing segment over the forecast period.
  • Some of the key players in this market are GE Healthcare, Allscripts Healthcare Solutions, McKesson Corporation, and Cerner Corporation. Developers are collaborating and expanding with the aim of combining the use of innovation and technology to improve efficiency and provide better services for the convenience of the providers.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global patient portal market based on type, delivery mode, end use, and region:

Type Outlook (Revenue, USD Million; 2015 – 2026)

  • Standalone
  • Integrated

Delivery Mode Outlook (Revenue, USD Million; 2015 – 2026)

  • Web-based
  • Cloud-based

End Use Outlook (Revenue, USD Million; 2015 – 2026)

  • Providers
  • Payers
  • Others

Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Patient Portal Market www.grandviewresearch.com/press-release/global-patient-portal-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Biochip Market Size To Hit USD 25.8 Billion By 2024 : Grand View Research Inc.

San Francisco, 30 August 2019: The Report Biochip Market Analysis By Type, (DNA Chips, Lab-On-a-Chip, Protein Chips, Cancer Diagnosis And Treatment, Gene Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), By End Use (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes), And Segment Forecasts To 2024

Global biochip market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth.

Anticipated launch and commercialization of novel products for diagnosis and treatment including laboratory- and non-laboratory-based research are expected to further reinforce growth in demand. Improvements in accuracy, resolution, and preparation procedures for the technology coupled with reduction in costs of associated materials are expected to fuel growth over the forecast period.

Ongoing developments related to further miniaturization of biochips are expected to enhance their applicability and additional usage for genetic sequencing methodologies, such as cancer genomics. Their usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024.

Access Research Report of Biochip Market www.grandviewresearch.com/industry-analysis/biochips-market

Further Key Findings From the Report Suggest:

  • DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA chips accounted for around a third of the global market revenue in 2015. The other notable contributing segments to application of biochips include gene expression, single nucleotide polymorphism genotyping, genomic studies, and agricultural biotechnology.
  • The market is expected to have a high potential for growth as the technology has numerous applications to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such miniaturization is expected to benefit medical technologies in terms of cost and input requirements.
  • DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end users like point-of-care settings, forensic labs, blood banks, etc.
  • North America was the largest revenue-generating region and accounted for over 45%of total revenue in 2015. This can be attributed to by the presence of government initiatives for personalized patient care coupled with the availability of a very large installed base of genetic and proteomic profiling platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer analysis projects in a number of academic and clinical research institutes are also responsible for the region’s large share.
  • Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Biochip market on the basis of type, end use, region:

Biochip Outlook, by Type (Revenue, USD Million, 2013 – 2024)

  • DNA chips, by application
    • Cancer diagnosis and treatment
    • Gene expression
    • Single Nucleotide Polymorphisms Genotyping
    • Drug discovery
    • Agricultural biotechnology
    • Others
  • Lab-on-a-chip, by application
    • Genomics
    • IVD & POC
    • Proteomics
    • Drug discovery
    • Others
  • Protein chips, by application
    • Proteomics
    • Expression Profiling
    • Diagnostics
    • HTS
    • Drug Discovery
    • Others
  • Tissue Arrays
  • Cell Arrays

Biochip Outlook, by End Use (Revenue, USD Million, 2013 – 2024)

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostics Centers
  • Academic & Research Institutes
  • Others

Biochip Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Biochip Market www.grandviewresearch.com/press-release/global-biochip-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Healthcare IT Market Value To Reach USD 104.5 Billion By 2020 : Grand View Research Inc.

San Francisco, 30 August 2019: The Report Healthcare IT Market Analysis By Application (Electronic Health Records, Computerized Provider Order Entry Systems, Electronic Prescribing Systems, PACS, Lab Information Systems, Clinical Information Systems, Telemedicine and Telehealth) And Segment Forecasts To 2020

The global healthcare IT market is anticipated to reach USD 104.5 billion by 2020, according to a new report by Grand View Research, Inc. Increasing demand for enhanced healthcare facilities and introduction of technologically advanced systems are expected to boost industry growth.

Increasing geriatric population prone to chronic diseases resulting into high patient base is triggering the demand for sophisticated healthcare facilities. Furthermore, increasing number of patients requiring home healthcare acts as an effective growth driver for this market.

Access Research Report of Healthcare IT Market www.grandviewresearch.com/industry-analysis/healthcare-it-market

According to a report published by the U.S. Centers for Disease Control and Prevention (CDC) in 2011, the number of patients needing home healthcare was nearly 4.7 million in the U.S. and is on a constant rise, which is further expected to fuel the healthcare IT market demand.

Advent of technologically advanced software, such as interoperable system and cloud computing, is expected to attract more investors focus on developing integrated healthcare system to curb problems associated with conventional procedures of record keeping. For example, the uses of e-healthcare record system to maintain patient database help to provide instant information about patients’ health in case of emergency.

Telecommunication and telehealth accounted for over 40.0% of the market share owing to the high usage rates in 2013. Introduction of technological advancements such as Teleimmersive Environment for Everybody (TEEVE) and Session Initiation Protocol (SIP) are the factors promoting this segment’s growth.

Electronic Health Records (EHR) is expected to register an upward shift to reach up to USD 26.72 billion in 2020. Growth is primarily driven by the rising demand for integrated information system in the field of healthcare IT. Faster accessibility and low maintenance cost are the two most significant factors contributing towards the rising demand of these EHR systems.

In 2013, North America market was valued at around USD 20.0 billion owing to the factors such as favorable government initiatives pertaining to the introduction of technologically advanced healthcare IT facilities, sophisticated healthcare infrastructure, and increasing patient awareness levels coupled with relatively higher healthcare expenditures in the region.

On the other hand, Asia Pacific healthcare IT market is expected to reach at over USD 19.6 billion by registering lucrative growth rate in 2020. Growth is attributed to the rising healthcare expenditure, larger untapped opportunities, and growing disposable income level.

Prominent players operating in this industry include Athenahealth Inc., GE Healthcare, Agfa Healthcare, Philips Healthcare, E-MDS Inc., Carestream Health McKesson Corporation, Carestream Health eClinicalworks, and Hewlett-Packard.

Browse more reports of this category by Grand View Research at:  www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global healthcare IT market on the basis of application and region:

Healthcare IT Application Outlook (Market Revenue in USD Million, 2012 – 2020)

  • Electronic Health Records
  • Computerized Provider Order Entry Systems
  • Electronic Prescribing Systems
  • PACS
  • Lab Information Systems
  • Clinical Information Systems
  • Telemedicine and Telehealth
  • Others

Healthcare IT Regional Outlook (Market Revenue in USD Million, 2012 – 2020)

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Access Press Release of Healthcare IT Market www.grandviewresearch.com/press-release/global-healthcare-it-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cell Counting Market Expected To Expand At USD 10,679.7 Million By 2025 : Grand View Research Inc.

San Francisco, 30 August 2019: The Report Cell Counting Market Analysis By Product (Instruments, Spectrophotometers, Flow Cytometers, Hemocytometers, Reagents, Microplates), By End-use, And Segment Forecasts, 2018 – 2025

The global cell counting market is expected to reach USD 10,679.7 million by 2025, according to a new report by Grand View Research, Inc. Government initiatives working to promote development of cell therapeutics, wherein cell counting plays an imperative role, is expanding growth prospects for the market. As a result of extensive R&D activities, the number of diseases treated with the help of stem cells increased to 82 in 2016 from 27 in 2005. Also, California Institute for Regenerative Medicine’s funding of USD 271 million for stem cell therapy created 12 R&D facilities in California, and these facilities brought approximately USD 543 million funding. In addition, it is also funded by National Institutes of Health (NIH), which approximately invested USD 1,429 million in 2015.

Increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided significant boost to the market. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate generation of accurate results are likely to improve adoption of instruments over the coming years. For instance, in May 2016, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve quality of preclinical studies.

Access Research Report of Cell Counting Market www.grandviewresearch.com/industry-analysis/cell-counting-market

Further Key Findings From the Report Suggest:

  • Spectrophotometers accounted forthe largest market share in 2016. This can be attributed to high penetration in various applications such as toxicology studies, bioprocessing, and others
  • Automated counters were anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and interoperator variability are expected to further increase demand for automated counters
  • In the end-use segment, research and academic institutes accounted for the largest market share in 2016, owing to growing number of government initiatives focused toward promoting R&D in various toxicology studies
  • Research and academic institutes are also expected to witness exponential growth opportunities, owing to the growing adoption of instruments for optimum drug concentration in therapeutics
  • North America held the largest share of the market, owing to increase in number of supportive initiatives to fund R&D, which is anticipated to result in higher adoption of automated instruments
  • Asia Pacific is anticipated to grow with a lucrative CAGR during the forecast period. This lucrative growth rate is a consequence of improvements in testing facilities
  • Level of competition is high as key players are adopting strategies such as new product development and strategic collaborations & agreements to gain competitive advantage

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global cell counting market on the basis of product, end use, and region:

Cell Counting Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Instruments
    • Spectrophotometers
    • Flow Cytometers
    • Hematology Analyzers
    • Cell Counters
  • Consumables & Accessories
    • Reagents
    • Microplates
    • Others

Cell Counting End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Cell Counting Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Cell Counting Market www.grandviewresearch.com/press-release/global-cell-counting-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

 

Empty Capsules Market Likely To Touch At USD 2.57 Billion By 2024 : Grand View Research Inc.

San Francisco, 30 August 2019: The Report Empty Capsules Market Analysis By Product (Gelatin, Non-Gelatin Capsules), By Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent Preparations, Anti-anemic Preparations, Anti-Inflammatory & Anti-rheumatic Drugs, Cardiac Therapy Drugs, Cough & Cold Preparations), By End-user(Pharmaceutical, Nutraceutical, Cosmetics Industries, Research laboratories) And Segment Forecasts To 2024

The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.

The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.

The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.

The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.

In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.

However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.

Access Research Report of Empty Capsules Market www.grandviewresearch.com/industry-analysis/empty-capsules-market

Further key findings from the study suggest:

  • In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
  • Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
  • In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
  • The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
  • The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
  • Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:

Global empty capsules market, by product (USD Million, 2013 – 2024)

  • Gelatin Capsules
  • Non-Gelatin capsules

Global empty capsules market by therapeutic application (USD Million, 2013 – 2024)

  • Antibiotic and antibacterial drugs
  • Vitamin and dietary supplements
  • Antacids and antiflatulent preparations,
  • Antianemic preparations,
  • Anti-inflammatory and anti-rheumatic drugs,
  • Cardiac therapy drugs,
  • Cough and cold preparations

Global empty capsules market by end-user (USD Million, 2013 – 2024)

  • Pharmaceutical industries
  • Nutraceutical industries
  • Cosmeceutical industries
  • Research laboratories

Empty capsules market, by region (USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Empty Capsules Market www.grandviewresearch.com/press-release/global-empty-capsules-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Peptide Therapeutics Market Projected To Ascend At The Fastest CAGR Of 9.4% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report Peptide Therapeutics Market By Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, Dermatology), By Type (Generic, Innovative) By Type of Manufacturers (In-house, Outsourced), And Segment Forecasts, 2018 – 2025

The global peptide therapeutics market is expected to reach USD 48.04 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for efficient & rapid-acting therapeutics for treatment of cancer and other lifestyle-associated disorders, which result in lesser adverse effects, are anticipated to propel market growth.

Rising incidence of cancer calls for exploring and introducing other means of therapies and low-cost treatment alternatives. Moreover, growing base of geriatric population is expected to widen the consumer base by triggering incidence rate of target diseases such as cancer & diabetes, which are expected to drive the demand for peptide therapeutics.

Technological advancements in peptide manufacturing process is one of the major factors driving the market growth during the forecast period. Manufacturers and suppliers are focusing on the adoption of novel technologies to manufacture efficient drug molecules with low time and capital investment. Improvement in purification & automation process and less generation of waste is an additional factor attributing toward market growth

Access Research Report of Peptide Therapeutics Market www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market

Further Key Findings From the Study Suggest:

  • Cancer held the largest market share in 2016 owing to increasing demand for alternative therapeutics over conventional treatment options. Peptides are being used as potential therapeutic agents in cancer treatment.
  • The generic drug segment is expected to showcase upward shift due to patent expiration of blockbuster peptides and supportive government initiatives pertaining to the introduction of generic class
  • Outsourced manufacturing is expected to grow at CAGR of 6.7% owing to requirements of complex procedures and shift in preference toward outsourcing, which helps in eliminating cost of production.
  • Route of administration including nasal and intradermal routes is expected to grow at a rapid pace owing to ease of usage and advantages over other routes of administration such as oral.
  • Hybrid technology is expected to spearhead the growth of this market. Benefits associated with this technology such as time conservation and ease of usage for both solid- and liquid-phase peptide synthesis are the key factors affirming growth.
  • North America held the largest share in terms of revenue in 2016 owing to higher level of awareness pertaining to genomics & proteomics products, well-established R&D infrastructure, and rising funding initiatives
  • Asia Pacific industry is expected to showcase lucrative growth over the forecast period with CAGR of 11.0%. Presence of established generic industry and API providers in this region coupled with growing economic stability in some of the countries is expected to propel market growth.
  • Some of the key players in the peptide therapeutics market include Eli Lilly and Company; Pfizer, Inc.; Amgen, Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceuticals Industries Ltd.; Lonza Inc.; Sanofi; Bristol-Myers Squibb (BMS); AstraZeneca PLC; GlaxoSmithKline plc (GSK); Novartis AG; and Novo Nordisk A/S

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the peptide therapeutics market by application, type, type of manufacturers, route of administration, synthesis technology, and region:

Peptide Therapeutics, Application Outlook (Revenue, USD Million; 2014 – 2025)

  • Cancers
  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Antiinfection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

Peptide Therapeutics, Type Outlook (Revenue, USD Million; 2014 – 2025)

  • Generic
  • Innovative

Peptide Therapeutics, Type of Manufacturers Outlook (Revenue, USD Million; 2014 – 2025)

  • In-house
  • Outsourced

Peptide Therapeutics, Route of Administration Outlook (Revenue, USD Million; 2014 – 2025)

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

Peptide Therapeutics, Synthesis Technology Outlook (Revenue, USD Million; 2014 – 2025)

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

Peptide Therapeutics, Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Peptide Therapeutics Market www.grandviewresearch.com/press-release/global-peptide-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Protein Expression Market Is Expected To Reach USD 3.0 Billion By 2025 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report Protein Expression Market By Expression Systems (Prokaryotic, Mammalian Cell), By Product (Reagents, Competent Cells), By Application (Therapeutic, Industrial), By End-use, And Segment Forecasts, 2018 – 2025

The global protein expression market is expected to reach USD 3.0 billion by the year 2025 growing at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing demand for biologics and expansion of the biopharmaceutical industry have resulted in massive growth of the protein expression market. Rising demand for therapeutic proteins such as insulin, hormones, monoclonal antibodies,and vaccines is a major factor that propels growth of the market during forecast period. Thus, many biotechnology and pharmaceuticals companies have begun to concentrate on the development and manufacturing of advanced therapeutic proteins for the treatment of severe chronic diseases such as cancer, hemophilia, infectious diseases, anemia, and multiple sclerosis.

Increasing investment in the R&D, by biotechnology and pharmaceutical companies, is another major factor supporting the sector growth. The availability of new and advanced technologies to cater the needs of drugs & biologics product manufacturers boosts the adoption of protein expression products for research and manufacturing applications. In addition, several pharmaceutical and biotechnology manufacturers are undergoing collaborations and partnerships to achieve leadership in the sector. For instance, in December 2016, Takara Bio, Inc. signed a merger agreement with Rubicon Genomics, Inc. to strengthen its genomics business.

Access Research Report of Protein Expression Market www.grandviewresearch.com/industry-analysis/protein-expression-market

Further Key Findings From The Report Suggest:

  • Prokaryotic expression systems segment was the largest revenue-generating amongst others owing to its large application in biologics and drug productions
  • Mammalian cell expression systems is the fastest growing segment of the protein expression market owing to its growing demand for proteomics research and biologics manufacturing
  • Reagents segment held the largest revenue share in the market, which is attributed to its repetitive purchase fortherapeutic, industrial, and research applications
  • The services segment is projected to grow at highest rate due to increasing trend of outsourcing of protein expression services by research labs and drug manufacturers
  • Therapeutic application segment was leading in 2016, due to high demand of therapeutic proteins for the treatment of cancer, infectious diseases, anemia, hemophilia, and multiple sclerosis
  • The pharmaceutical and biotechnological companies segment dominated the sector in terms of revenue in 2016 due to rising focus on proteomics research and increasing production of biologics products
  • North America was the leading regional market in 2016 and is expected to maintain its dominance during the forecast period, because of the presence of large number of biopharmaceutical and biotechnology companies in this region
  • The Asia Pacific region is projected to grow at a highest CAGR during the forecast period owing to untapped opportunities in the developing countries including China and India
  • Some of the major players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen, and Takara Bio, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global protein expression market on the basis of expression systems, product, application, end-use, and region:

Expression Systems Outlook (Revenue, USD Million; 2014 – 2025)

  • Prokaryoticexpression systems
  • Mammalian cell expression systems
  • Insect cell expression systems
  • Yeast expression systems
  • Other expression systems

Product Outlook (Revenue, USD Million; 2014 – 2025)

  • Reagents
  • Competent cells
  • Expression vectors
  • Services
  • Instruments

Application Outlook (Revenue, USD Million; 2014 – 2025)

  • Therapeutic
  • Industrial
  • Research

End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Pharmaceutical and biotechnological companies
  • Academic research
  • Contract research organizations
  • Others

Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Protein Expression Market www.grandviewresearch.com/press-release/global-protein-expression-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Healthcare 3D Printing Market Segmented On The Basis Of Application , Technology , Raw Material , And Forecast to 2020 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report  Healthcare 3D Printing Market Analysis By Application (Surgical Guides, Implants, Surgical Instruments, Bioengineering), By Technology (Electron Beam Melting, Stereolithography, Droplet Deposition Manufacturing), By Raw Material (Metals, Biological Cells, Polymers, Ceramics) And Segment Forecast to 2020

The global healthcare 3D printing market is estimated to grow at a CAGR of 15.6% from 2014 to 2020 on account of growing need for manufacturing automated products. Rising geriatric population and increasing healthcare requirements across the globe have been majorly driving demand. Rise in number of orthopaedic and cardiovascular disorders occurring prominently among the aged population have resulted in an increased demand for these printing facilities.

Healthcare 3D printing market provides significant opportunities for manufacturing various medical equipment including dental implants, prosthetic limbs, hearing aids and orthotic footwear. Government initiatives to develop healthcare infrastructure and rising investments for R&D are some of the factors driving growth. The ability of the technology to reduce the risks involved with anaesthesia during prolonged surgeries has been another factor resulting in their increasing demand.The market is estimated to be worth USD 1.13 billion by 2020.

Polymers captured over 35% of the overall market share in 2013, dominating the raw material segment of the healthcare 3D printing industry. They are primarily used in bio-model printing.

Access Research Report of Healthcare 3D Printing Market www.grandviewresearch.com/industry-analysis/healthcare-3d-printing-market

Ceramics are commonly used for manufacturing tooth or mandible (jaw bone). Increasing occurrences of tooth problems including fractures and decays resulting in replacement of crowns or entire teeth is expected to propel demand for biocompatible materials including ceramics. The market is expected to grow at a CAGR of 15.6% over the forecast period.

Implants accounted for over 60.0% of the global market share in 2013. They are not only cost effective but also provide accuracy which is expected to fuel demand. Customized orthopaedic implants increase performance as they reduce time duration of surgeries. Also, it is convenient and less expensive to tailor 3D printed parts. Dental printers provide metal and wax prosthetics. Rising consumer awareness regarding maintaining oral health is expected to bolster growth over the projected period.

Photo-polymerization technology is extensively utilized by research organizations to produce accurate and efficient bio-models. It was valued over USD 140.0 million in 2013 dominating the global industry. However, laser beam melting is estimated to grow at a CAGR exceeding 16% from 2014 to 2020, thus, becoming the fastest growing technology. It is mostly used for producing orthopaedic implants.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

North America accounted for over 35% of the global revenue dominating the regional industry in 2013. Rising awareness among patients, mounting investments for dedicated R&D facilities, advanced healthcare infrastructure coupled with development of 3D printing-based products are expected to drive demand in the region over the forecast period.

Rising demand for customized medical equipments and huge investments in R&D programs in Europe are expected to make it the fastest growing market in the next few years. Increasing healthcare investments and expenditures in emerging economies of Asia Pacific are expected to drive demand at a rapid pace over a period of six years.

Prominent players in the industryinclude Envision TEC, Materialise NV, Stratasys Inc., 3D Systems Software, Organovo, Bio-Rad Laboratories, SOLS, Metamason, Simbionix, RegenHU Ltd., Youbionic, 3D Matters Pte Ltd., 3D Systems Corporation (3DS), Roche Pharmaceuticals, Ekso Bionics, Renishaw plc., Delcam India, Robohand, Worrell, Archam, ALD Vacuum Technologies and Rainbow Biosciences.

Access Press Release of Healthcare 3D Printing Market www.grandviewresearch.com/press-release/global-healthcare-3d-printing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Design a site like this with WordPress.com
Get started